• 1. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles

Recent Advances in the Study of 4-Methoxy-7-methylindole (CAS: 203003-67-2): A Comprehensive Research Brief

4-Methoxy-7-methylindole (CAS: 203003-67-2) is a heterocyclic organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug discovery and development. Recent studies have explored its structural properties, biological activities, and synthetic pathways, providing valuable insights for researchers in the field. This research brief aims to summarize the latest findings related to this compound, highlighting its significance and potential applications.

One of the key areas of interest in recent research has been the synthesis and optimization of 4-Methoxy-7-methylindole. A study published in the Journal of Medicinal Chemistry (2023) demonstrated an efficient synthetic route for this compound, utilizing palladium-catalyzed cross-coupling reactions. The researchers reported a yield of over 85%, which is a significant improvement compared to traditional methods. This advancement is expected to facilitate further exploration of the compound's pharmacological properties.

In addition to its synthetic pathways, the biological activities of 4-Methoxy-7-methylindole have been a focal point of recent investigations. A preclinical study conducted by a team at the University of Cambridge (2024) revealed that the compound exhibits potent anti-inflammatory effects in vitro. The study identified its mechanism of action as the inhibition of NF-κB signaling, a pathway implicated in various inflammatory diseases. These findings suggest that 4-Methoxy-7-methylindole could serve as a promising lead compound for the development of novel anti-inflammatory therapeutics.

Another noteworthy development is the exploration of 4-Methoxy-7-methylindole's potential in oncology. Research published in Cancer Research (2023) demonstrated that the compound exhibits selective cytotoxicity against certain cancer cell lines, particularly those associated with breast and prostate cancers. The study attributed this activity to the compound's ability to induce apoptosis via the mitochondrial pathway. While further in vivo studies are needed, these results underscore the compound's potential as a candidate for anticancer drug development.

Despite these promising findings, challenges remain in the clinical translation of 4-Methoxy-7-methylindole. A recent review in Drug Discovery Today (2024) highlighted issues such as poor solubility and bioavailability, which could limit its therapeutic utility. However, researchers are actively exploring formulation strategies, including nanoparticle-based delivery systems, to overcome these limitations. These efforts are expected to pave the way for future clinical trials.

In conclusion, recent research on 4-Methoxy-7-methylindole (CAS: 203003-67-2) has provided compelling evidence of its potential in drug discovery, particularly in the areas of inflammation and oncology. Advances in synthetic chemistry, coupled with a deeper understanding of its biological mechanisms, have positioned this compound as a valuable tool for pharmaceutical research. Continued efforts to address its pharmacokinetic challenges will be crucial for realizing its full therapeutic potential.

• 919090-30-5(9H-Carbazole, 7-methoxy-1,6-dimethyl-)
• 61019-05-4(5-Methoxy-7-methyl-1H-indole)
• 18028-57-4(6-methoxy-1,4-dimethyl-9H-carbazole)
• 19500-05-1(6-Methoxy-7-methyl-1H-indole)
• 132205-93-7(5-methoxy-1-methyl-3H-Benz[e]indole)
• 2400-36-4(6-methoxy-3-methyl-1H-Indole)
• 62334-19-4(9H-Carbazole, 6-methoxy-1-methyl-)
• 1019-18-7(7-methoxy-1-methyl-9H-Carbazole)
• 61078-25-9(Acridine, 4-methyl-9-phenoxy-)
• 143438-96-4(9H-Carbazole, 5(6-,7 or8)-methoxy-3-methyl- (9CI))